- Home
- Platforms
- GlycoNano™ Platform
- Glyconanoparticle Formulation
Glyconanoparticle Formulation Service

CD BioGlyco is committed to providing a full range of glyconanoparticle formulation services from development to preclinical studies for biomedical, agricultural, cosmetic, nutraceutical, and imaging fields to help clients accelerate their research process. We are at the forefront of industry innovation and design customized glyconanoparticle formulations to meet diverse application needs.
Exploring Glyconanoparticle Applications Through Cutting-edge Technology
Our services cover glyconanoparticle design, optimization, and application analysis, including material selection, detailed characterization, evaluation of delivery efficiency, and detailed preclinical studies. Small molecule drugs, moisturizing factors, biomacromolecules, multifunctional ingredients, etc., are encapsulated into glyconanoparticles.

Glyconanoparticle Development
Glyconanoparticle enables precisely targeted delivery by interacting with specific receptors. When designing glyconanoparticles, we consider several aspects and detailed application needs, including the following:
- Surface properties of the glyconanoparticle: Glyconanoparticle is designed to avoid its adsorption to proteins or blood cells and premature phagocytosis by endothelial cells.
- Functional groups of glyconanoparticles: Glyconanoparticles utilize functional groups on the surface to couple ligands with specific recognition.
- The particle size of glyconanoparticle: The particle size of glyconanoparticle needs to be appropriate to facilitate the delivery of the active substance across the cell membrane to the specific site and to prolong the circulation time in the bloodstream.
- Biodegradability of glyconanoparticles: Glyconanoparticles should be biodegradable so that they are easily metabolized by the human body after accomplishing the corresponding tasks.
Based on our well-established GlycoNano™ Platform and rich experience in nano research, the types of glyconanoparticles we offer are:
In addition, we also develop Glycol Nanohydrogel for biopharmaceuticals, cosmetics, and agriculture.
| Types | Glycol Nanohydrogel |
|---|---|
| Natural Polymer-based Glycol Nanohydrogel |
|
| Synthetic Polymer-based Glycol Nanohydrogel |
|
Glyconanoparticle Characterization
Glyconanoparticle characterization involves several aspects, including Physicochemical Properties characterization and Interaction Analysis. Through detailed characterization, we provide a comprehensive and in-depth understanding of glyconanoparticles to support their applications in drug delivery, vaccine development, bioimaging, and disease treatment.
- Particle size and morphology: The particle size and particle size distribution of glyconanoparticles are measured using techniques such as dynamic light scattering (DLS), transmission electron microscopy (TEM), or scanning electron microscopy (SEM).
- Zeta potential: Zeta potential has an important effect on particle stability. We measure the zeta potential of glyconanoparticles by electrophoresis to understand the nature of the surface charge.
- Structural analysis and chemical characterization: X-ray diffraction (XRD), infrared spectroscopy (FTIR), and nuclear magnetic resonance (NMR) are used to analyze the functional groups, composition, and precise structure of glyconanoparticles to ensure their integrity and functionality.
- Interaction analysis: We analyze the binding affinity of glyconanoparticles and detect their interactions with carbohydrates, lipids, proteins, nucleic acids, etc., to ensure targeted delivery of active substances.
Glyconanoparticle Preclinical Studies
We provide very comprehensive glyconanoparticle preclinical study services to analyze its biocompatibility, embedding efficiency, release kinetics, targeting, cytotoxicity, safety, etc., which include the following:
| Topic | Service | |
|---|---|---|
| Stability Study | ||
| Biological Characterization | ||
| Pharmacodynamic Study |
|
|
| Pharmacokinetic Study |
|
|
| Safety Pharmacology |
|
|
Our Glyconanoparticle Formulation Service

Glyconanoparticles are used as carriers to carry drug molecules and deliver them precisely to the lesion site through specific biological pathways for effective drug utilization and reduction of side effects. We carefully design glyconanoparticles and provide a one-stop drug-loaded glyconanoparticle formulation service to reliably support drug research and disease treatment development.
- Neurological Drug Loaded Glyconanoparticle Formulation Service
- Anticarcinogen Loaded Glyconanoparticle Formulation Service
- Cardiovascular Disease Drug Loaded Glyconanoparticle Formulation Service
- Skin Disease Drug Loaded Glyconanoparticle Formulation Service
- Bone Disease Drug Loaded Glyconanoparticle Formulation Service
- Eye Disease Drug Loaded Glyconanoparticle Formulation Service
- Antiviral Drug Loaded Glyconanoparticle Formulation Service
- Antifungal Drug Loaded Glyconanoparticle Formulation Service
- Anti-inflammatory Drug Loaded Glyconanoparticle Formulation Service
- Painkiller Loaded Glyconanoparticle Formulation Service

We design and synthesize glyconanoparticles with excellent biocompatibility and functionality as effective carriers for the delivery of biologics. Their structures are characterized and analyzed to ensure that they are structurally stable, have a uniform particle size, and have the desired biologics loading. In addition, a detailed preclinical evaluation of the glyconanoparticle is performed to ensure that it meets the needs of the application.
- Nucleic Acid Loaded Glyconanoparticle Formulation Service
- Peptide Loaded Glyconanoparticle Formulation Service
- Antibody Loaded Glyconanoparticle Formulation Service
- Anti-HIV Prodrug Loaded Glyconanoparticle Formulation Service
- Glycan Antigen Prodrug Loaded Glyconanoparticle Formulation Service

Glyconanoparticles have good potential for diagnostic applications. In this service, we develop high-quality glyconanoparticles and efficiently deliver diagnostic reagents to specific biological targets, enhancing imaging and diagnostic capabilities in medical applications. In addition to this, we rigorously characterize nanoparticle size, stability, and release kinetics to ensure optimal performance for in vitro or in vivo diagnostic applications.
- Magnetic Loaded Glyconanoparticle Formulation Service
- Fluorescent Probe Loaded Glyconanoparticle Formulation Service
- Imaging Contrast Agent Loaded Glyconanoparticle Formulation Service
- Radioisotope Loaded Glyconanoparticle Formulation Service

We offer customized nutrient-loaded glyconanoparticle formulation services. We precisely load nutrients (e.g., vitamins, minerals, dietary fiber, fatty acids, etc.) onto glyconanoparticles. This strategy effectively improves the stability, bioavailability, and targeting of nutrients, thereby enhancing their absorption, transport, and utilization efficiency in the body.
- Vitamin Loaded Glyconanoparticle Formulation Service
- Mineral Loaded Glyconanoparticle Formulation Service
- Essential Fatty Acid Loaded Glyconanoparticle Formulation Service
- Probiotics Loaded Glyconanoparticle Formulation Service
- Prebiotics Loaded Glyconanoparticle Formulation Service
- Dietary Fiber Loaded Glyconanoparticle Formulation Service
- Antioxidant Loaded Glyconanoparticle Formulation Service

We focus on the field of cosmetics and utilize glyconanoparticle as a carrier to efficiently and stably load active ingredients (e.g. antioxidants, whitening ingredients, moisturizing factors, etc.) in cosmetics. By optimizing the process parameters and the properties of glyconanoparticles, we achieve uniform distribution and high loading of cosmetic ingredients, while improving their permeability, slow-release, and bioavailability on the skin, thus enhancing the efficacy and durability of the cosmetic products.
- Protein and Peptide Loaded Glyconanoparticle Formulation Service
- Moisturizing and Barrier Repair Ingredient Loaded Glyconanoparticle Formulation Service
- Sunscreen Loaded Glyconanoparticle Formulation Service
- Other Functional Ingredient Loaded Glyconanoparticle Formulation Service

This service focuses on the innovative development of glyconanoparticles, which are specifically designed for the efficient delivery of agrochemicals such as fungicides, herbicides, and fertilizers. We utilize a variety of biodegradable materials to carefully functionalize glyconanoparticles, enhancing their affinity for plant surfaces or specific root systems to facilitate targeted application. Through detailed characterization and research, we aim to enhance crop yields by enabling precision treatments using cutting-edge nanotechnology.
- Insecticide Loaded Glyconanoparticle Formulation Service
- Plant Bactericide Loaded Glyconanoparticle Formulation Service
- Herbicide Loaded Glyconanoparticle Formulation Service
- Fertilizer Loaded Glyconanoparticle Formulation Service
- Plant Growth Regulator Loaded Glyconanoparticle Formulation Service
- Soil Conditioner Loaded Glyconanoparticle Formulation Service
Workflow
Glyconanoparticle formulation services begin with the preliminary design and selection of appropriate materials. We then synthesize the glyconanoparticle using appropriate methods and characterize it to ensure that it meets the need. After that, we conduct comprehensive preclinical studies to ensure its use in pharmaceutical, cosmetic, and agricultural applications, and make improvements based on the results of these studies.

Applications
- Glyconanoparticles are widely used for the delivery of various drugs and enhancement of antimicrobial efficacy and have important applications in therapeutic research for oncology, neurological diseases, and other disease.
- Glyconanoparticles have important applications in delivering imaging agents, as they bind to specific receptors to enable precise localization and imaging of cells or tissues.
- Glyconanoparticles have important applications in agricultural management, such as delivering fertilizers, fungicides, etc.
Advantages
- We have deep expertise and hands-on experience in glyconanoparticle formulation and offer end-to-end services.
- We have a wide range of glyconanoparticle preparation technologies and precisely control their size and distribution to achieve high performance.
- Strict quality control ensures that glyconanoparticles are suitable for use in various fields such as biopharmaceuticals, cosmetics, and agriculture.
Publication Data
Journal: Biomedical Reports
IF: 2.3
Published: 2024
Results: This paper details nanoparticles (gold, copper, silver, silicon, zinc, and selenium nanoparticles) and their applications in inhibiting various viruses. Due to their unique physicochemical properties, nanoparticles have been used as novel antimicrobial agents against various viral infections, especially influenza A virus. For example, gold nanoparticles exhibit antiviral results when covalently bound to other molecules, which can significantly enhance the antiviral effect. Silver nanoparticles, which have good solubility and high stability, can also provide some antiviral effects.
Fig.1 Nanoparticles for antiviral applications. (Rios-Ibarra, et al., 2024)
Frequently Asked Questions
- Is the developed glyconanoparticle customizable?
Yes, this service includes the customization of glyconanoparticles. We customize and optimize the composition, size, surface chemistry, and release properties of the glyconanoparticle according to specific project requirements. - What types of testing and characterization do we perform?
We use a variety of testing and characterization techniques to evaluate the physical and chemical properties of glyconanoparticles, including:- Size and shape analysis
- Surface charge testing
- Drug loading and release studies
- Toxicity and biocompatibility assessments
- Stability testing
- Pharmacology and pharmacodynamics analysis
- Other types of analysis
CD BioGlyco strives to create superior glyconanoparticle formulation services to meet the needs of increasingly complex scientific discovery in a variety of fields, including pharmaceuticals and biotechnology. Please feel free to contact us for further inquiries or to discuss specific project requirements.
Reference
- Rios-Ibarra, C.P.; et al. Nanoparticle‑based antiviral strategies to combat the influenza virus. Biomedical Reports. 2024, 20(4): 65.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform
- Drug Loaded Glyconanoparticle Formulation Service
- Biological Agent Loaded Glyconanoparticle Formulation Service
- Diagnostic Agent Loaded Glyconanoparticle Formulation Service
- Nutrient Loaded Glyconanoparticle Formulation Service
- Cosmetic Ingredient Loaded Glyconanoparticle Formulation Service
- Agricultural Chemical Loaded Glyconanoparticle Formulation Service





